Protagonist Therapeutics, Inc (PTGX)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

($2.49M) Net Amount

Buy:	0	--
Sell:	($2.49M)	$30.69 - $35.19

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

1

(2)

0

(1)

12

0

4

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
11-Mar-24 8:00 PM View:	07-Mar-24 Option Exercise $12.27K	Selick Harold E Director		Protagonist Therapeutics, Inc - PTGX	30% 21.51K to 28.0K	0	0	--	--	Show Txns Hide Txns

12-Sep-24 7:38 PM View:	10-Sep-24 Planned Option Sale ($360.00K)	Waddill William D. Director		Protagonist Therapeutics, Inc - PTGX	0% 12.0K	0	0	--	--	Show Txns Hide Txns

28-Feb-24 8:00 PM View:	26-Feb-24 Payment of Exercise ($126.45K)	Gupta Suneel Chief Development Officer		Protagonist Therapeutics, Inc - PTGX	9% 168.32K to 183.28K	0	0	--	--	Show Txns Hide Txns

13-Sep-24 4:35 PM View:	11-Sep-24 Sale ($98.01K)	Ali Asif Chief Financial Officer		Protagonist Therapeutics, Inc - PTGX	13% 31.04K to 34.96K	0	($305.05K) (32%)	--	$30.69	Show Txns Hide Txns

Yesterday 4:01 PM View:	19-Nov-24 Gift 0	Patel Dinesh V Ph D President and CEO Director		Protagonist Therapeutics, Inc - PTGX	(16%) 609.35K to 513.41K	0	($2.18M) (11%)	--	$31.62 - $35.19	Show Txns Hide Txns

19-Nov-24 6:49 PM View:	15-Nov-24 Private Sale ($78.11K)	Molina Arturo Md Chief Medical Officer		Protagonist Therapeutics, Inc - PTGX	106% 22.53K to 46.44K	0	0	--	--	Show Txns Hide Txns